The Wilms’ tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy

The Wilms tumor gene WT1 is a useful marker of clonal hematopoiesis and it has been shown to be a good marker of residual disease and it reflects the response to therapy. Although myelofibrosis is characterized by mutations of JAK2 and calreticulin (CALR), these mutations are not useful to monitor r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Med
Hauptverfasser: Gallo, Daniela, Nicoli, Paolo, Calabrese, Chiara, Gaidano, Valentina, Petiti, Jessica, Rosso, Valentina, Signorino, Elisabetta, Carturan, Sonia, Bot‐Sartor, Giada, Volpe, Gisella, Frassoni, Francesco, Saglio, Giuseppe, Cilloni, Daniela
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2016
Schlagworte:
Commentary
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4867666/
https://ncbi.nlm.nih.gov/pubmed/27167495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.735
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge